-

2022 Bladder Cancer Update Bulletin: Key Opinion Leader (KOL) Views on Recent Developments - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bladder Cancer: Update Bulletin #2" newsletter has been added to ResearchAndMarkets.com's offering.

This edition presents leading key opinion leader (KOL) views on recent developments in the Bladder Cancer market.

Topics covered include: Bristol-Myers Squibb (BMS) presenting positive data from a Phase I/II study investigating a combination of its PD-1 inhibitor Opdivo (nivolumab) with its pipeline indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, BMS-986205, in heavily pretreated patients with advanced bladder cancer; BioCanCell announcing final results for its Phase IIb combination trial investigating its lead compound BC-819 in combination with the BCG vaccine in 38 patients with intermediate-and high-risk non-muscle invasive bladder cancer (NMIBC); KOLs offering their updated opinions on the the supply status of the BCG vaccine in the US and key European markets.

Business Questions:

  • How do the KOLs perceive the Phase II combination results for BMS' Opdivo with the IDO inhibitor BMS-986205 in patients with advanced bladder cancer?
  • Do KOLs view PD-1/PD-L1 and IDO inhibition as a viable combination approach going forward?
  • What are experts' thoughts on PD-L1 expression and its future use as a biomarker in patients with bladder cancer?
  • Do KOLs hold any other concerns about dual immunotherapy combinations such as cost, access or increased risk of toxicity?
  • If approved, how and when would KOLs consider using the combination approach of Opdivo with an IDO inhibitor?
  • Based on published Phase II data, how do the experts view the results so far for BC-819 with BCG in patients with NMIBC?
  • Are the KOLs enthusiastic about intravesical gene therapies as treatments for NMIBC and if so, why?
  • How do the experts perceive the planned Phase III trial investigating BC-819 in patients that are BCG-recurrent?
  • If approved, can BC-819 gain market share in patients with high-risk or intermediate-risk NMIBC?
  • What are KOLs' opinions on the supply shortages previously reported for the BCG vaccine and are they being addressed?

For more information about this newsletter visit https://www.researchandmarkets.com/r/9ke1kl

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

IoT Mobile Virtual Network Operators (MVNO) Market Business Report 2025-2030: Growth in Smart Cities and Connected Utilities Drives Adoption of IoT MVNO Services - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "IoT Mobile Virtual Network Operators (MVNO) Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for IoT Mobile Virtual Network Operators (MVNO) was valued at US$2.7 Billion in 2024 and is projected to reach US$6.5 Billion by 2030, growing at a CAGR of 15.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed busine...

AI Hardware Industry Report 2025-2035: Regional Market Sizing and Opportunity Analysis, Competitive Landscape, Company Profiles, SWOT Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI Hardware Market Till 2035: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global AI hardware market is poised for exponential growth, expanding from USD 31.40 billion in the current year to a projected USD 624.4 billion by 2035, achieving a CAGR of 31.23%. This surge is driven by increasing demand for advanced processing capabilities to support intricate AI workloads and computational tasks. AI Hardware Market: Gro...

AI Chips Present an $846.8 Billion Global Market Opportunity by 2035: Insights Into Chips, Processing Types, Technologies, Functions, Applications, End-Users, Enterprises, Regions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI Chip Market, Till 2035: Distribution by Type of Chip, Type of Processing, Type of Technology, Type of Function, Type of Application, Type of End-User, Type of Enterprise and Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global AI chip market is experiencing remarkable expansion, projected to soar from USD 31.6 billion in the current year to an impressive USD 846.8 billion by 2035. This equate...
Back to Newsroom